NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover of Inivata, a liquid biopsy platform company based in Cambridge, England. The deal was announced in May 2021 by NeoGenomics as it exercised a purchase option to acquire the remaining equity interest in Inivata. A year prior […]
GE Healthcare has unveiled new Serena Bright, a contrast-enhanced mammography solution for biopsy, which is claimed to help clinicians to detect breast cancer patients in a better way. The company claimed that SenoBright HD contrast-enhanced spectral mammography is an imaging tool for diagnosis that has the potential to detect malignant lesions which cannot be seen […]